Product Description
| Brand |
Cepheid |
| Sample Type |
PCR Kit |
| Pack Size |
10T |
| CAT No |
GXSACOMP-10 |
| Application |
Molecular Biology |
Xpert SA Nasal Complete is a qualitative in vitro diagnostic test designed for rapid detection of S. aureus and methicillin resistant S. aureus (MRSA) from nasal swabs in patients at risk for nasal colonization. Rapid identification of S. aureus nasal carriers followed by immediate implementation infection control strategies can reduce the number of surgical-site S. aureus infections acquired in the hospital by nearly 60%.
Rapid Detection and DifferentiationCepheid Xpert SA Nasal Complete leverages real-time PCR technology for the swift and precise identification of SA and MRSA in nasal swab specimens. With results available in just about 60 minutes, this assay supports urgent clinical decisions for infection control and preoperative screening, enhancing workflow and patient management.
User-Friendly Cartridge SystemThe assay utilizes disposable, compact cartridges compatible with Cepheid GeneXpert Systems. Each cartridge contains an internal process control for validation, built-in barcode for traceability, and is designed for single patient use, minimizing cross-contamination risk and simplifying the workflow for healthcare professionals.
Safe and Reliable Diagnostic SolutionDesigned with non-hazardous, medical-grade plastic components, the Xpert SA Nasal Complete offers a high level of accuracy (over 97%), superior batch traceability, and compliance with global diagnostic standards. Its easy storage at ambient temperatures and long shelf life ensure reliability and convenience for laboratories and clinics.
FAQ's of Cepheid Xpert SA Nasal Complete:
Q: How does Cepheid Xpert SA Nasal Complete detect infections?
A: The Xpert SA Nasal Complete uses advanced PCR (Polymerase Chain Reaction) technology to identify and differentiate Staphylococcus aureus (SA) and MRSA DNA from nasopharyngeal swab specimens. This enables highly accurate and rapid detection for effective infection control.
Q: What is the typical process for sample testing with this assay?
A: To test a sample, collect a nasopharyngeal swab specimen, insert it into the single-use cartridge, and load the cartridge into a Cepheid GeneXpert System. The system automatically processes the sample, and results are typically ready in about 60 minutes, with integrated controls for quality assurance.
Q: When is the Xpert SA Nasal Complete most beneficial in clinical practice?
A: This assay is highly valuable for preoperative screening, infection prevention, and rapid diagnosis of SA and MRSA in patients. Its fast turnaround time helps expedite clinical decision-making, especially in high-throughput environments like hospitals and diagnostic laboratories.
Q: Where should the cartridges be stored for optimal performance?
A: Store the Xpert SA Nasal Complete cartridges in a dry environment at an ambient temperature between 2 and 28C. Proper storage is essential to maintain its shelf life of up to 12 months and ensure test reliability.
Q: What are the main advantages of using this product over traditional methods?
A: Compared to conventional culture-based methods, Xpert SA Nasal Complete offers faster turnaround, high accuracy (97%+), qualitative detection capabilities, and built-in controls for process validation. Its automation and single-use format reduce the risk of cross-contamination and improve workflow efficiency.
Q: Is special training required to operate the Xpert SA Nasal Complete assay?
A: Minimal training is needed, as the test process is largely automated through the Cepheid GeneXpert System. User instructions are provided, and the design emphasizes ease of use for both clinical and laboratory personnel.